Snapshot

Atorvastatin is a pharmaceutical raw material in the production of atorvastatin drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL cholesterol as well.
The global Atorvastatin market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Atorvastatin by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Chemical Synthesis
Biocatalysis

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
DSM Sinochem Pharmaceuticals
Pfizer
Ind-Swift
Cadila Pharmaceuticals
Morepen
Sun Pharmaceutical Industries
MSN Laboratories
Dr. Reddy's
Teva Pharmaceutical Industries
Apotex Pharmachem
Zheijang Neo-Dankon Pharmaceutical
Ningbo Menovo Pharmaceuticals Group
Jialin Pharmaceutical
Topfond
Zhejiang Hisun Pharmacutical
Zhejiang Hongyuan Pharmaceutical
Hubei Yitai Pharmaceutical
Jiangsu Hengrui Medicine.

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Tablet (including dispersible tablet and general tablet)
Capsule
Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)